Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
01/2009
01/22/2009US20090023196 Stocks of replication-deficient adenovirus
01/22/2009US20090022725 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases
01/21/2009EP1596667B1 Process for the concentration of proteins
01/21/2009EP1569680B1 Treatment of diabetes
01/20/2009USRE40624 An isolated nucleic acid encoding the ASKRK polypeptide comprising an amino acid identification sequence #2; nucleotide sequences; expression vector; pancreatic beta host cell. antidiabetic agents; non-insulin dependent diabetes
01/20/2009US7479548 Synthesizing 2'- beta -substituted phosphoramidites with pendent amine and carboxylate groups, oligomerization, coupling the pendent groups to form a nylon-DNA ladder copolymer; DNA nanotechnology; inhibition of antisense agent biosynthesis
01/20/2009CA2108473C Heregulins (hrgs) binding proteins of p185erb2
01/15/2009US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis
01/14/2009EP2014770A2 WNT-1 Iinduced secreted polypeptide WISP-2
01/14/2009EP2014298A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
01/14/2009EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it
01/14/2009EP1604016B1 Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence of additional cytokines
01/13/2009US7476519 Screening chemical libraries to identify compounds using expressed RNA; high throughput assay
01/08/2009US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use
01/08/2009US20090012267 Anti-hydroxylase antibodies and uses thereof
01/08/2009US20090012016 Short Interfering Rna and Micro-Rna Compounds and Methods of Designing, Making, and Using the Same
01/08/2009US20090011496 comprises supplementing the culture medium with a prostaglandin in an amount effective to promote complete hatching of the embryo (i.e., freeing of the embryo from the zona pellucida); in vitro fertilization embryo is thereby enhanced and establishment of a viable pregnancy is facilitated
01/08/2009US20090010930 Antibodies to vla-1
01/07/2009EP1687400A4 Cell culture methods and devices utilizing gas permeable materials
01/07/2009EP1407008B1 Influenza vaccine composition
01/07/2009EP1115874B1 Alzheimer's disease secretase
01/07/2009CN100448893C Humanized antibodies that recognize beta amyloid peptide
01/06/2009US7473770 Indentifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor; useful for treating osteoporosis and other bone loss disorders.
01/01/2009US20090007283 Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein
01/01/2009US20090005545 Methods for purifying radiolabelled compounds
01/01/2009US20090005329 Synthesizing 2'- beta -substituted phosphoramidites with pendent amine and carboxylate groups, oligomerization, coupling the pendent groups to form a nylon-DNA ladder copolymer; DNA nanotechnology; inhibition of antisense agent biosynthesis
01/01/2009US20090005311 Expression vector comprising nucleotide sequences coding fructooligosaccharide (FOS)-related protein for enhancing ability of probiotic bacteria to compete in the gastrointestinal tract of mammals
01/01/2009US20090004706 Methods to enhance the activity of lignocellulose-degrading enzymes
01/01/2009US20090004698 Methods to enhance the activity of lignocellulose-degrading enzymes
01/01/2009US20090004692 Methods to enhance the activity of lignocellulose-degrading enzymes
01/01/2009US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/2008
12/31/2008EP1579212B1 Methods of identifying reduced internalization transmembrane receptor agonists
12/30/2008CA2132349C Chimeric receptor genes and cells transformed therewith
12/25/2008US20080318896 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA
12/25/2008US20080318238 Method of detecting gene mutation
12/25/2008US20080317747 Recombinant anti-cd30 antibodies and uses thereof
12/25/2008US20080317738 Mylks as Modifiers of Branching Morphogenesis and Methods of Use
12/24/2008EP1639087A4 Biological data set comparison method
12/23/2008US7468269 Expression vector comprising nucleotide sequences coding recombinase inhibitor for use in treatment and prevention of viral infcetion and diseases
12/23/2008US7468256 Tools for detecting Moraxella catarrhalis
12/23/2008US7468181 Means and methods for the production of adenovirus vectors
12/18/2008US20080311150 Novel sequences encoding hepatitis C virus glycoproteins
12/17/2008EP2003451A2 T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
12/17/2008EP2003196A2 Compositions and methods for treating and diagnosing cancer
12/17/2008EP1614426B1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
12/16/2008US7465565 Using transgenic yarrowia as biorector for production of omega-3 or omega-6 fatty acids
12/16/2008US7465562 RNA and DNA, are freed from bound proteins by incubation with a chaotropic agent such as a guanidium salt
12/16/2008US7465449 Anti-αvβ6 antibodies
12/11/2008US20080306244 Renta: an HIV immunogen and uses thereof
12/10/2008EP1590482B1 Nucleic acid amplification using non-standard bases
12/09/2008US7462487 Serum free nutrient broth comprised of fructose for use in propagation of cells and improving recombinant and/or endogenous protein synthesis; bioreactors
12/09/2008US7462352 Methods of treatng B-cell diseases using humanized anti-CD19 antibodies
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
12/04/2008US20080300191 Cbz-Leu-Gln-fluoromethyl ketone; 4-(Cbz-Val-Leu-amido)-6-fluoro-5-oxo-hexanoic acid dimethylamide; 4-(Cbz-Leu-amido)-6-Fluoro-5-oxo-hexanoic acid methylamide; 4-(Cbz-Ile-amido)-6-fluoro-5-oxo-hexanoic acid methylamide; 4-(Cbz-Val-amido)-6-fluoro-5-oxo-hexanoic acid methylamide
12/04/2008US20080300145 In vivo high throughput selection of RNAi probes
12/04/2008US20080299614 Metabolically Engineered Bacterial Strains Having Non-Functional Endogenous Gluconate Transporters
12/04/2008US20080299153 B. anthracis prevention and treatment: mutant b. anthracis lacking luxs activity and furanone inhibition of growth, ai-2 quorum sensing, and toxin production
12/03/2008EP1794280B1 A reactor and method for solid state fermentation
12/03/2008EP1613737A4 Artificial receptors including reversibly immobilized building blocks and methods
12/02/2008US7459547 Determination competitive binder between Rna and target compound in plants
12/02/2008US7459299 Variant Humicola grisea CBH1.1
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008CA2484533C Systems and method of embryo delivery for manufactured seeds
12/02/2008CA2348377C Human orphan g protein-coupled receptors
11/2008
11/27/2008US20080293580 Methods for Detecting and Measuring Specific Nucleic Acid Sequences
11/27/2008US20080292546 Compositions and methods for treating and diagnosing cancer
11/26/2008EP1618217A4 Bcl2l12 polypeptide activators and inhibitors
11/25/2008US7456315 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/25/2008US7456179 Administering 3-aminopyridine-2-carboxaldehyde thiosemicarbazone for therapy of coronary artery bypass graft surgery, global cerebral ischemia, focal cerebral infarction, cerebral hemorrhage, hemorrhage infarction, hypertensive hemorrhage, intracranial vascular hemorrhage, subarachnoid hemorrhage
11/25/2008US7455843 useful for enhancing immune response to antigens; vaccines; applicable to mucosal immunization in humans
11/25/2008CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/20/2008US20080288085 Vivo synthesis of connective tissues
11/20/2008US20080287380 Antisense Oligonucleotides Against Cpla2, Compositions and Uses Thereof
11/20/2008US20080286847 Inhibiting multimeric porphobilinogen synthase; for use as drug, toothpaste, soap, disinfectant, anti-biofilm and herbicide
11/19/2008EP1487978B1 An improved method for synthesising templated molecules
11/19/2008EP1358213B1 Humanized antibodies that recognize beta amyloid peptide
11/19/2008CN101309930A Splice variants of erbb ligands, compositions and uses thereof
11/19/2008CN100433975C High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa
11/18/2008US7452699 Genetic replication of template nucleic acid sequence that reduces polymerase-induced errors; ligation, geneitc engineering; polymerase chain reactions
11/18/2008US7452678 biomarker polypeptides for determining if a test substance will cause hepatotoxicity; kits
11/13/2008US20080280356 Expression vector for use as transformation and gene transfer agent
11/13/2008US20080280286 Compositions and Methods for Gene Expression
11/13/2008US20080279873 Active immunization to generate antibodies to soluble a-beta
11/12/2008EP1606389B1 Methods for polynucleotide sequence detection
11/12/2008CN101302500A Vaccine
11/12/2008CN101301475A Peg化因子vii糖型 Peg factor vii sugar type
11/11/2008US7449550 Superactive cellulase formulation using cellobiohydrolase-1 from Penicillium funiculosum
11/11/2008US7449303 Use of JAG2 expression in diagnosis of plasma cell disorders
11/11/2008US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders
11/06/2008WO2008132743A2 Production of high mannose proteins in plant culture
11/06/2008WO2005028633A3 Modulation of rankl expression
11/06/2008US20080274505 Polynucleotide encoding a novel TRP channel family member, LTRPC3, and splice variants thereof
11/06/2008US20080274122 Plks as Modifiers of the Beta Catenin Pathway and Methods of Use
11/06/2008CA2685400A1 Production of high mannose proteins in plant culture
11/05/2008EP1664275A4 In vivo synthesis of connective tissues
11/05/2008CN100430481C Nucleotide sequences regulating gene expression and constructs and methods utilizing same
11/05/2008CN100430477C Hamster EF-1 'alpha' transcriptional regulatory DNA
11/05/2008CN100430418C Method of preparing monoclonal antibody, monoclonal antibody, pharmaceutical composition and diagnostic reagent
11/04/2008US7445926 Fluid control structures in microfluidic devices
10/2008
10/30/2008WO2005017110A3 Engineered proteases for affinity purification and processing of fusion proteins
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 100